Search Results for "New Treatment For Hepatitis B"

02:24 EDT 24th August 2016 | BioPortfolio

Matching Channels

Hepatitis B

Hepatitis A

Hepatitis C

Most hepatitis C virus (HCV) infected individuals seeking treatment are chronically infected. Treatment goal is to achieve a sustained virological response (SVR), which is the absence of serum HCV R...

Hepatitis E virus HEV

Hepatitis B virus HBV

Matching News

Deciding on the Best Treatment in Patients With Hepatitis B

Recent recommendations and their impact on the management of patients with hepatitis B, including immune-tolerant hepatitis B, immune-active hepatitis B, and inactive chronic hepatitis, are reviewed. ...

Introducing Epclusa

The treatment options for hepatitis C infections just gained a member to the club. There are six genotypes (numbered 1-6) of the hepatitis C virus. Previously, hepatitis C medications generally worked...

The Hepatitis C Trust considers legal action over cap on NHS patients allowed to seek treatment

NHS England is limiting treatment with new drugs for hepatitis C to 10,000 of the most in-need patients, prompting The Hepatitis C Trust to consider seeking a judicial review of the decision.

Longevity After Hepatitis C Treatment

Before direct-acting antiviral medications came on the scene for treating hepatitis C, this disease was often a death sentence for patients who progressed to liver failure or liver cancer. However, ov...

Hepatitis C Treatment Delivery Mandates

This Viewpoint describes how a shortage of health care workers providing treatment for hepatitis C hinders access to treatment, despite progress in drug efficacy and reductions in drug costs.

Mycophenolate mofetil effective as first-line treatment for autoimmune hepatitis

In a real-world retrospective study, researchers found mycophenolate mofetil treatment to be safe and effective for the treatment of autoimmune hepatitis in treatment-naive patients, according to publ...

FDA approves a Gilead pill that is first to treat all forms of hepatitis C

The drug maker's new treatment can be used for all six strains of hepatitis C, and at about $75,000 for a 12-week course of treatment, it costs less than two…

Pharmalot, Pharmalittle: New $300 hepatitis C treatment in development

A nonprofit is working with an Egyptian drug maker to develop a combination hepatitis C treatment that will sell for less than $300.

Matching PubMed Articles

The Cascade of Care for an Australian Community-Based Hepatitis C Treatment Service.

Hepatitis C treatment uptake in Australia is low. To increase access to hepatitis C virus treatment for people who inject drugs, we developed a community-based, nurse-led service that linked a viral h...

The New Era of Interferon-Free Treatment of Chronic Hepatitis C.

Within the development and approval of several new direct-acting antivirals (DAA) against hepatitis C virus (HCV), a new era of hepatitis C therapy has begun. Even more treatment options are likely to...


Occult hepatitis B infection is characterized by negative hepatitis B surface antigen (HBsAg) and also detectable hepatitis B virus (HBV) -DNA, with or without hepatitis B core antibody (anti-HBc). HB...

Management and treatment of patients with hepatitis B.

Chronic hepatitis B is a major cause of morbidity and mortality worldwide. Approximately one third of the world's population has serological evidence of past or present infection by hepatitis B virus ...

Efficacy and safety of entecavir versus tenofovir treatment in chronic hepatitis B patients: A randomized controlled trial.

Entecavir (ETV) and Tenofovir Disoproxil Fumarate (TDF) have been considered among the most potent antiviral agents for the treatment of chronic hepatitis B infection. We aimed to compare treatment ef...

Search Whole site using Google

Quick Search
Advertisement Advertisement